CS-5006

N/A

Report date: 2025/04/16 15:55:46

Base Information

Drug NameCS-5006
Drug Alias NameCS-5006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Integrin Subunit Beta 4
TargetsIntegrin Subunit Beta 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A